|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254.40 EUR | -1.97% |
|
-1.59% | +6.62% |
| 07-03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| Market Cap | 48.43B 55.41B 44.61B 41.38B 78.7B 5,286B 79.65B 533B 207B 2,594B 208B 204B 8,981B | P/E 2026 * |
27.4x | P/E 2027 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 48.16B 55.1B 44.36B 41.15B 78.26B 5,257B 79.21B 530B 206B 2,579B 207B 202B 8,930B | EV / Sales 2026 * |
5.64x | EV / Sales 2027 * | 4.79x |
| Free-Float |
61.59% | Yield 2026 * |
0.58% | Yield 2027 * | 0.59% |
Last Transcript: UCB
| 1 day | -1.97% | ||
| 1 week | -1.59% | ||
| Current month | -2.90% | ||
| 1 month | -2.53% | ||
| 3 months | -3.82% | ||
| 6 months | +8.30% | ||
| Current year | +6.62% |
| 1 week | 252.6 |  | 268.3 |
| 1 month | 243.3 | | 275.5 |
| Current year | 223 | | 289.5 |
| 1 year | 165.1 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-15 | Buy | Director | 500 | 0.0003% | ||
| 01-15 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 01-15 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.97% | -1.59% | +50.62% | +218.16% | 56.51B | |
| -0.68% | +2.67% | +18.72% | -9.48% | 66.56B | |
| -1.13% | +40.50% | +40.50% | +40.50% | 42.98B | |
| +1.99% | +8.15% | -48.83% | -54.69% | 40.46B | |
| -3.54% | -3.50% | +56.89% | -27.08% | 31.91B | |
| +2.56% | +21.60% | +168.28% | -33.79% | 31.65B | |
| -1.06% | +1.64% | +68.91% | +83.55% | 23.35B | |
| +3.08% | +20.43% | +4.99% | +186.85% | 19.46B | |
| +0.21% | +2.96% | +66.67% | +129.01% | 17.18B | |
| +0.73% | +10.69% | +76.74% | +344.54% | 15.12B | |
| Average | -0.22% | +9.25% | +50.35% | +87.76% | 34.52B | |
| Weighted average by Cap. | -0.53% | +7.82% | +43.53% | +64.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.76B 7.86B 7.29B 13.87B 932B 14.04B 93.95B 36.56B 457B 36.67B 35.86B 1,582B | 9.63B 11.02B 8.88B 8.23B 15.66B 1,052B 15.85B 106B 41.28B 516B 41.4B 40.49B 1,787B |
| Net income | 1.75B 2B 1.61B 1.49B 2.84B 191B 2.87B 19.24B 7.49B 93.58B 7.51B 7.34B 324B | 2.26B 2.59B 2.09B 1.93B 3.68B 247B 3.72B 24.92B 9.7B 121B 9.73B 9.51B 420B |
| Net Debt | -271M -310M -250M -232M -441M -29.61B -446M -2.99B -1.16B -14.53B -1.17B -1.14B -50.31B | -2.31B -2.65B -2.13B -1.98B -3.76B -252B -3.8B -25.47B -9.91B -124B -9.94B -9.72B -429B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | €254.40 | -1.97% | 169,111 |
| 03/07/26 | €259.50 | -1.93% | 131,923 |
| 02/07/26 | €264.60 | +2.60% | 212,407 |
| 01/07/26 | €257.90 | -1.56% | 217,639 |
| 30/06/26 | €262.00 | -0.57% | 270,371 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
